← Leaderboards
Anil Kumar Chauhan
University Of Iowa
$14,298,095
Attributed
$16,047,455
Total exposure
10
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2013–25$5M$3.8M$2.5M$1.3M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,047,455 · 10
By mechanism
R01$7,252,032 · 6
R35$5,296,703 · 1
U01$2,877,999 · 2
T32$620,721 · 1
Top collaborators
- Enrique Carlos Leira6 shared
- Steven R Lentz2 shared
Others in their field
Top investigators on “Pre-Clinical”
- Leonard Freedman · Leidos Biomedical Research, Inc.$264,541,531
- Dennis R. Burton · Scripps Research Institute$257,157,696
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barton F Haynes · Duke University$186,001,832
- David Heimbrook · Leidos Biomedical Research, Inc.$151,740,590
- Reisa A. Sperling · Banner Health$137,047,788
Research focus
Pre-ClinicalStrokeThrombosisIschemic StrokeReperfusion TherapyInnovationIschemiaUnited StatesBlood PlateletsIntravital MicroscopyHigh RiskAcuteInflammationStroke TherapyThromboinflammationGeneticPilot ProjectsBrain InjuriesMacrophageImproved OutcomeFunctional DisorderGuidelinesCoagulation ProcessMutant
Grant awards (32)
Metabolic Reprogramming in Experimental Deep Vein Thrombosis and Resolution$765,223
R01 · FY2025 · HL · contact PI
Regulating Cellular Metabolism and Energy Flow to Target Thrombosis$713,538
R01 · FY2025 · HL · contact PI
Platelet function abnormalities underlying bleeding in a connective tissue disorder the Ehlers Danlos syndrome$660,681
R01 · FY2025 · HL · contact PI
The University of Iowa Stroke Preclinical Assessment Network to Support Translational Studies for Acute Cerebroprotection$544,713
U01 · FY2025 · NS
Program in Hematology: Molecular & Cell Biology of Blood Cells$265,138
T32 · FY2025 · HL
Targeting Pyruvate Kinase M2: A novel strategy to combat thrombo-inflammation$743,663
R35 · FY2024 · HL · contact PI
The University of Iowa Stroke Preclinical Assessment Network to Support Translational Studies for Acute Cerebroprotection$594,621
U01 · FY2024 · NS
Program in Hematology: Molecular & Cell Biology of Blood Cells$355,583
T32 · FY2024 · HL
Targeting Pyruvate Kinase M2: A novel strategy to combat thrombo-inflammation$758,840
R35 · FY2023 · HL · contact PI
The University of Iowa Stroke Preclinical Assessment Network to Support Translational Studies for Acute Cerebroprotection$622,000
U01 · FY2023 · NS
Novel therpeautic interventions to treat ischemic stroke$468,887
R01 · FY2023 · NS · contact PI
Targeting Pyruvate Kinase M2: A novel strategy to combat thrombo-inflammation$758,840
R35 · FY2022 · HL · contact PI
Novel therpeautic interventions to treat ischemic stroke$314,267
R01 · FY2022 · NS · contact PI
Targeting Pyruvate Kinase M2: A novel strategy to combat thrombo-inflammation$758,840
R35 · FY2021 · HL · contact PI
The University of Iowa Stroke Preclinical Assessment Center for Neuroprotection in stroke$500,395
U01 · FY2021 · NS
Novel therpeautic interventions to treat ischemic stroke$322,637
R01 · FY2021 · NS · contact PI
Targeting Pyruvate Kinase M2: A novel strategy to combat thrombo-inflammation$758,840
R35 · FY2020 · HL · contact PI
The University of Iowa Stroke Preclinical Assessment Center for Neuroprotection in stroke$500,395
U01 · FY2020 · NS
Novel therpeautic interventions to treat ischemic stroke$322,637
R01 · FY2020 · NS · contact PI
Targeting Pyruvate Kinase M2: A novel strategy to combat thrombo-inflammation$758,840
R35 · FY2019 · HL · contact PI
Novel therpeautic interventions to treat ischemic stroke$323,658
R01 · FY2019 · NS · contact PI
The University of Iowa Stroke Preclinical Assessment Center for Neuroprotection in stroke$115,875
U01 · FY2019 · NS
Targeting Pyruvate Kinase M2: A novel strategy to combat thrombo-inflammation$758,840
R35 · FY2018 · HL · contact PI
Mechanisms of Fibronectin Extra Domain A in Atherosclerosis$377,500
R01 · FY2017 · HL · contact PI
Fibronectin alternative splicing in thrombosis and inflammation$377,500
R01 · FY2017 · HL · contact PI
Mechanisms of Fibronectin Extra Domain A in Atherosclerosis$377,500
R01 · FY2016 · HL · contact PI
Fibronectin alternative splicing in thrombosis and inflammation$377,500
R01 · FY2016 · HL · contact PI
Mechanisms of Fibronectin Extra Domain A in Atherosclerosis$371,837
R01 · FY2015 · HL · contact PI
Fibronectin alternative splicing in thrombosis and inflammation$371,837
R01 · FY2015 · HL · contact PI
Fibronectin alternative splicing in thrombosis and inflammation$377,500
R01 · FY2014 · HL · contact PI
Mechanisms of Fibronectin Extra Domain A in Atherosclerosis$369,950
R01 · FY2014 · HL · contact PI
Mechanisms of Fibronectin Extra Domain A in Atherosclerosis$359,380
R01 · FY2013 · HL · contact PI